Literature DB >> 24899417

Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase virus subtype or neuraminidase antibody specificity.

Janice C Pedersen1.   

Abstract

The neuraminidase-inhibition (NI) assay is a laboratory procedure for the identification of the neuraminidase (NA) glycoprotein subtype in influenza viruses or the NA subtype specificity of antibodies to influenza virus. A serological procedure for subtyping the NA glycoprotein is critical for the identification and classification of avian influenza (AI) viruses. The macroprocedure was first described in 1961 by Aminoff and was later modified to a microtiter plate procedure (micro-NI) by Van Deusen et al. (Avian Dis 27:745-750, 1983). The micro-NI procedure reduces the quantity of reagents required, permits the antigenic classification of many isolates simultaneously, and eliminates spectrophotometric interpretation of results. Although, the macro-NI has been shown to be more sensitive than the micro-NI, the micro-NI test is very suitable for testing sera for the presence of NA antibodies and has proven to be a practical and rapid method for virus classification. This chapter provides an overview of the USDA validated micro-NI procedure for the identification of subtype-specific NA in AIV and antibodies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899417     DOI: 10.1007/978-1-4939-0758-8_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Evaluation of two multiplex RT-PCR assays for detection and subtype differentiation of Brazilian swine influenza viruses.

Authors:  Vanessa Haach; Danielle Gava; Maurício Egídio Cantão; Rejane Schaefer
Journal:  Braz J Microbiol       Date:  2020-03-03       Impact factor: 2.476

2.  Widespread detection of highly pathogenic H5 influenza viruses in wild birds from the Pacific Flyway of the United States.

Authors:  S N Bevins; R J Dusek; C L White; T Gidlewski; B Bodenstein; K G Mansfield; P DeBruyn; D Kraege; E Rowan; C Gillin; B Thomas; S Chandler; J Baroch; B Schmit; M J Grady; R S Miller; M L Drew; S Stopak; B Zscheile; J Bennett; J Sengl; Caroline Brady; H S Ip; E Spackman; M L Killian; M K Torchetti; J M Sleeman; T J Deliberto
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.